Improving Surgeon Performance Measures for Robot-Assisted Surgery

Sponsor
Memorial Sloan Kettering Cancer Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT06037837
Collaborator
(none)
1,000
7
36
142.9
4

Study Details

Study Description

Brief Summary

The purpose of this study is to develop new tools to understand surgeon performance to improve surgical training and participant outcomes after surgery.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Robotic Surgery

Study Design

Study Type:
Observational
Anticipated Enrollment :
1000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Generalized Robotic Skills Assessment Using Machine Learning-Based Analysis Across Multiple Surgical Specialties
Actual Study Start Date :
Aug 24, 2023
Anticipated Primary Completion Date :
Aug 24, 2026
Anticipated Study Completion Date :
Aug 24, 2026

Arms and Interventions

Arm Intervention/Treatment
Robotic surgeons

Participants will be robotic surgeons in urologic, gynecologic, colorectal, hepatobiliary, gastric, and thoracic surgery

Procedure: Robotic Surgery
Surgeons will perform and participants will undergo robotic surgery according to the standard of care. No additional interventions will be performed on participating participants.

Outcome Measures

Primary Outcome Measures

  1. Correlation of Automated Performance Metrics to surgeon experience [Up to 2 years]

    For the primary objective, we will capture Automated Performance Metrics/APMs and will determine the association between these and other metrics and surgeon experience, which will be used to construct validation. APMs that will be used in the study: Time Metrics Camera Metrics Instrument Metrics System Metrics Articulation Metrics

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
Surgeon inclusion criteria:
  • Performs robotic surgery for candidate procedures

  • Performs candidate procedures that are frequently performed by at least three surgeons (to ensure the ability to make adequate comparisons)

  • Agrees to participate in the study

Patient inclusion criteria:
  • Aged 18 years or older

  • Scheduled to undergo a robot-assisted surgical procedure involving the prostate, kidney, bladder, colon, pancreas, gallbladder, stomach, uterus, or lung

Exclusion Criteria:
Patient exclusion criteria:
  • Scheduled to undergo multiple panel procedures

  • Scheduled to undergo hybrid procedures involving open and robot-assisted techniques

o Hybrid procedures will involve multiple surgeons from different subspecialties, include certain rare steps, and require the surgeons' improvisation to complete such procedures safely; to avoid data heterogeneity, we have elected to exclude such procedures

  • Refusal to consent to data capture during the procedure

Contacts and Locations

Locations

Site City State Country Postal Code
1 Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge New Jersey United States 07920
2 Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown New Jersey United States 07748
3 Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale New Jersey United States 07645
4 Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities ) Commack New York United States 11725
5 Memorial Sloan Kettering Westchester (Limited Protocol Activities) Harrison New York United States 10604
6 Memorial Sloan Kettering Cancer Center (All protocol activites) New York New York United States 10065
7 Memorial Sloan Kettering Nassau (Limited Protocol Activites) Rockville Centre New York United States 11553

Sponsors and Collaborators

  • Memorial Sloan Kettering Cancer Center

Investigators

  • Principal Investigator: Alvin Goh, MD, Memorial Sloan Kettering Cancer Center

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Memorial Sloan Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT06037837
Other Study ID Numbers:
  • 23-094
First Posted:
Sep 14, 2023
Last Update Posted:
Sep 14, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Memorial Sloan Kettering Cancer Center

Study Results

No Results Posted as of Sep 14, 2023